ALBT Stock Summary and Trading Ideas (Avalon Globocare Corp. | NASDAQ:ALBT)

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Avalon Globocare Corp. trades on the NASDAQ stock market under the symbol ALBT.

As of April 2, 2026, ALBT stock price climbed to $0.58 with 214,642 million shares trading.

ALBT has a beta of 1.86, meaning it tends to be more sensitive to market movements. ALBT has a correlation of 0.05 to the broad based SPY ETF.

ALBT has a market cap of $3.33 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ALBT traded as high as $36.75 and as low as $.42.

The top ETF exchange traded funds that ALBT belongs to (by Net Assets): VXF.

ALBT has underperformed the market in the last year with a return of -87.9%, while the SPY ETF gained +17.5%. In the last 3 month period, ALBT fell short of the market, returning -53.7%, while SPY returned -3.7%. However, in the most recent 2 weeks ALBT has outperformed the stock market by returning +6.3%, while SPY returned -0.1%.

ALBT support price is $.48 and resistance is $.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALBT shares will trade within this expected range on the day.